NYSE · Healthcare
Bausch Health Companies Inc. (BHC)
As-reported financials and recent SEC filings for Bausch Health Companies Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$10.27B
Net income
$157.0M
Net margin
1.5%
Diluted EPS
$0.42
ROE
41.6%
P/E (TTM)
11.3×
Market cap
$1.78B
Debt / equity
54.6×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $10.27B | $9.63B | $8.76B | $8.12B | $8.43B |
| Gross profit | — | — | — | — | — |
| Operating income | $1.81B | $1.55B | $963.0M | $454.0M | $450.0M |
| Net income | $157.0M | $-46.0M | $-592.0M | $-225.0M | $-948.0M |
| Diluted EPS | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SD2026-06-01
View on EDGAR →42026-05-26
View on EDGAR →42026-05-26
View on EDGAR →42026-05-26
View on EDGAR →42026-05-26
View on EDGAR →42026-05-26
View on EDGAR →42026-05-26
View on EDGAR →42026-05-26
View on EDGAR →Go deeper on BHC
Search Bausch Health Companies Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.